A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors

JOURNAL ARTICLE published June 2021 in European Urology Oncology

Authors: Ali Raza Khaki | Ang Li | Leonidas N. Diamantopoulos | Natalie J. Miller | Lucia Carril-Ajuria | Daniel Castellano | Ivan De Kouchkovsky | Vadim Koshkin | Joseph Park | Ajjai Alva | Mehmet A. Bilen | Tyler Stewart | Victor Santos | Neeraj Agarwal | Jayanshu Jain | Yousef Zakharia | Rafael Morales-Barrera | Michael Devitt | Ariel Nelson | Christopher J. Hoimes | Evan Shreck | Benjamin A. Gartrell | Alex Sankin | Abhishek Tripathi | Roubini Zakopoulou | Aristotelis Bamias | Alejo Rodriguez-Vida | Alexandra Drakaki | Sandy Liu | Vivek Kumar | Mark P. Lythgoe | David J. Pinato | Jure Murgic | Ana Fröbe | Monika Joshi | Pedro Isaacsson Velho | Noah Hahn | Lucia Alonso Buznego | Ignacio Duran | Marcus Moses | Pedro Barata | Matthew D. Galsky | Guru Sonpavde | Evan Y. Yu | Veena Shankaran | Gary H. Lyman | Petros Grivas